We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japan Sets Conditional Pathway For Regenerative Drugs
Japan Sets Conditional Pathway For Regenerative Drugs
Sponsors of regenerative drugs can now get a conditional approval in Japan based on limited data, under a new regulatory pathway meant to speed patient access to novel therapies.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor